Cargando…
Growth Suppression of Mouse Pituitary Corticotroph Tumor AtT20 Cells by Curcumin: A Model for Treating Cushing's Disease
BACKGROUND: Pituitary corticotroph tumors secrete excess adrenocorticotrophic hormone (ACTH) resulting in Cushing's disease (CD). Standard treatment includes surgery and, if not successful, radiotherapy, both of which have undesirable side effects and frequent recurrence of the tumor. Pharmacot...
Autores principales: | Bangaru, Madhavi Latha Yadav, Woodliff, Jeffrey, Raff, Hershel, Kansra, Sanjay |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2854133/ https://www.ncbi.nlm.nih.gov/pubmed/20405005 http://dx.doi.org/10.1371/journal.pone.0009893 |
Ejemplares similares
-
Correction: Growth Suppression of Mouse Pituitary Corticotroph Tumor AtT20 Cells by Curcumin: A Model for Treating Cushing's Disease
por: Bangaru, Madhavi Latha Yadav, et al.
Publicado: (2010) -
Effects of epigenetic pathway inhibitors on corticotroph tumour AtT20 cells
por: Lines, K E, et al.
Publicado: (2020) -
MON-469 Pituitary Corticotroph Lesions: Clinical, Biochemical, and Pathological Characterization of Cushing Disease, Silent Corticotroph Adenomas, and Corticotroph Hyperplasia
por: Castlen, Joseph, et al.
Publicado: (2019) -
Neuromedin B Receptor Antagonist Suppresses Pomc Expression in AtT-20 Cells and Human Corticotroph Adenoma Cells
por: Sekizaki, Tomonori, et al.
Publicado: (2021) -
Inhibition of Ubiquitin-specific Peptidase 8 Suppresses Adrenocorticotropic Hormone Production and Tumorous Corticotroph Cell Growth in AtT20 Cells
por: Jian, Fang-Fang, et al.
Publicado: (2016)